Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Gastroenterology

• Publication date

  1995-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0016-5085(95)90692-4PMID 7729636
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunoregulatory role of interleukin 10 in rheumatoid arthritis

  1994cited by this paper
• Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation

  1994cited by this paper
• The role of interleukin-1 in disease.

  1993cited by this paper
• Enhand secretion of tumour necrosis factor‐alpha, IL‐6, and IL‐1β by isolated lamina ropria monouclear cells from patients with ulcretive cilitis and Crohn's disease

  1993cited by this paper
• Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease.

  1993cited by this paper
• Analytical performances of commercial ELISA-kits for IL-2, IL-6 and TNF-alpha. A WHO study.

  1993cited by this paper
• Interleukin 10 protects mice from lethal endotoxemia

  1993cited by this paper
• Crohn's disease monocytes are primed for accentuated release of toxic oxygen metabolites.

  1993cited by this paper
• Interleukin-10.

  1992cited by this paper
• Enhanced mucosal cytokine production in inflammatory bowel disease.

  1992cited by this paper
• Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis.

  1992cited by this paper
• Increased concentrations of interleukin 1 beta, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease.

  1992cited by this paper
• IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells.

  1992cited by this paper
• Increased in vitro release of soluble interleukin 2 receptor by colonic lamina propria mononuclear cells in inflammatory bowel disease.

  1992cited by this paper
• IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor.

  1992cited by this paper
• Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease.

  1992cited by this paper
• IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function.

  1992cited by this paper
• IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity.

  1992cited by this paper
• Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

  1991cited by this paper
• Power of oesophageal peristalsis can be controlled voluntarily.

  1991cited by this paper
• Regulation of immune responses by T cells with different cytokine secretion phenotypes: role of a new cytokine, cytokine synthesis inhibitory factor (IL10).

  1991cited by this paper
• Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI.

  1991cited by this paper
• Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel disease.

  1991cited by this paper
• IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells.

  1991cited by this paper
• Interleukin-1 and interleukin-1 antagonism.

  1991cited by this paper
• IL-10 inhibits cytokine production by activated macrophages.

  1991cited by this paper
• Role of interleukin 1 in inflammatory bowel disease--enhanced production during active disease.

  1990cited by this paper
• Tumour necrosis factor‐alpha and interferon‐gamma production measured at the single cell level in normal and inflamed human intestine

  1990cited by this paper
• Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis.

  1990cited by this paper
• Quantitation of mRNA by the polymerase chain reaction.

  1989cited by this paper
• Interleukin-1 in the pathogenesis of and protection from inflammatory bowel disease

  1989cited by this paper
• Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease.

  1989cited by this paper
• Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

  1989cited by this paper
• Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.

  1989cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens.

  1987cited by this paper
• Electrocardiograms and exercise test in a health check. A study on forest workers.

  1969cited by this paper
• Isolation of mononuclear cells and granulocytes from human blood.

  1968cited by this paper
• lnterleukin-10-Deficient Mice Develop Chronic Enterocolitis

  year unknowncited by this paper

• Interleukin Signatures as Prognostic Biomarkers in Ulcerative Colitis: From Immune Pathways to Clinical Prediction.

  2026cites this paper
• Efficacy and safety of the interleukin-10–fragment F8 fusion protein PF-06687234 as add-on therapy to infliximab in patients with active ulcerative colitis: a randomized, phase IIa clinical trial

  2026cites this paper
• Palmitic Acid Esterification Boosts Epigallocatechin Gallate’s Immunomodulatory Effects in Intestinal Inflammation

  2025cites this paper
• Peripheral monocytes from Crohn’s disease patients retain functional responsiveness to GM-CSF during active disease

  2025cites this paper
• The role of efferocytosis in inflammatory bowel disease

  2025cites this paper
• Single-cell transcriptomic characterization of microscopic colitis

  2025cites this paper
• Next Generation Probiotics as potential therapeutic supplement for gastrointestinal infections

  2024cites this paper
• Postbiotics in inflammatory bowel disease: efficacy, mechanism, and therapeutic implications.

  2024cites this paper
• Experimental colitis-induced visceral hypersensitivity is attenuated by GABA-treatment in mice.

  2024cites this paper
• Effects of a Combined Chinese Herbal Medicine on Growth Performance, Intestinal Barrier Function, Immune Response, and Cecal Microflora in Broilers Infected with Salmonella enteritidis

  2024cites this paper
• Host-derived Bacillus antagonistic novel duck reovirus infection by regulating gut microbiota-mediated immune responses.

  2024cites this paper
• Investigating the association between the tissue expression of miRNA‐101, JAK2/STAT3 with TNF‐α, IL‐6, IL‐1β, and IL‐10 cytokines in the ulcerative colitis patients

  2024cites this paper
• Effects of fecal microbiota transplantation and fecal virome transplantation on LPS-induced intestinal injury in broilers

  2023cites this paper
• Addressing safety concerns of long-term probiotic use: In vivo evidence from a rat model

  2023cites this paper
• Chronic stress adds fuel to gut flame

  2023cites this paper
• The association of interleukin-10 single nucleotide polymorphisms (rs1800871) and serum levels in Iraqi patients with celiac disease: A case-control study

  2023cites this paper
• Correlation of ex vivo cytokine secretion profiles with scoring indices in ulcerative colitis

  2023cites this paper
• Artemisia argyi extract alleviates inflammation in a DSS-induced colitis mouse model and enhances immunomodulatory effects in lymphoid tissues

  2022cites this paper
• Effects of bacteriophage supplement on the growth performance, microbial population, and PGC-1α and TLR4 gene expressions of broiler chickens

  2022cites this paper
• Pro-inflammatory and anti-inflammatory cytokines as candidate markers in the diagnosis and assessment of Crohn’s disease activity

  2022cites this paper
• Probiotics-loaded nanoparticles attenuated colon inflammation, oxidative stress, and apoptosis in colitis

  2022cites this paper
• Therapeutic Potential of Quercetin Loaded Nanoparticles: Novel Insights in Alleviating Colitis in an Experimental DSS Induced Colitis Model

  2022cites this paper
• Strategies for the Identification and Assessment of Bacterial Strains with Specific Probiotic Traits

  2022cites this paper
• Selection of a novel strain of Christensenella minuta as a future biotherapy for Crohn’s disease

  2022cites this paper
• Targeted therapy of irritable bowel syndrome with anti-inflammatory cytokines

  2021cites this paper
• Ulcerative colitis: shedding light on emerging agents and strategies in preclinical and early clinical development

  2021influential citation
• Targeting inflammation and redox aberrations by perindopril attenuates methotrexate-induced intestinal injury in rats: Role of TLR4/NF-κB and c-Fos/c-Jun pro-inflammatory pathways and PPAR-γ/SIRT1 cytoprotective signals.

  2021cites this paper
• Animal Models for Probiotic Interventions Under Gut Inflammatory Conditions

  2021cites this paper
• Association between IL-10 rs3024505 and susceptibility to inflammatory bowel disease: A systematic review and meta-analysis.

  2021cites this paper
• Enterococcus faecium Alleviates Gut Barrier Injury in C57BL/6 Mice with Dextran Sulfate Sodium-Induced Ulcerative Colitis

  2021cites this paper
• High-Density-Immune-Complex Regulatory Macrophages Promote Recovery of Experimental Colitis in Mice

  2021cites this paper
• Interplay between Cytokine Circuitry and Transcriptional Regulation Shaping Helper T Cell Pathogenicity and Plasticity in Inflammatory Bowel Disease

  2020cites this paper
• Gout: a disease involved with complicated immunoinflammatory responses: a narrative review

  2020cites this paper
• An immune therapy model for effective treatment on inflammatory bowel disease

  2020cites this paper
• IGF-1C hydrogel improves the therapeutic effects of MSCs on colitis in mice through PGE2-mediated M2 macrophage polarization

  2020cites this paper
• The Role of the Anti-Inflammatory Cytokine Interleukin-10 in Tissue Fibrosis

  2020cites this paper
• Sudachinoid- and Ichangensin-Type Limonoids from Citrus junos Downregulate Pro-Inflammatory Cytokines

  2020cites this paper
• Vitamin D in Children With Inflammatory Bowel Disease

  2020cites this paper
• A Novel Fusion of IL-10 Engineered to Traffic across Intestinal Epithelium to Treat Colitis

  2020cites this paper
• Microbes, microglia, and pain

  2020cites this paper
• Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases

  2020cites this paper
• Effect of Dietary Amylose/amylopectin Ratio on Diarrhea and Gut Microorganism of Weaned Pigs Challenged With Escherichia Coli Lipopolysaccharide

  2020cites this paper
• One‐Pot Synthesis of pH‐Responsive Eudragit‐Mesoporous Silica Nanocomposites Enable Colonic Delivery of Glucocorticoids for the Treatment of Inflammatory Bowel Disease

  2020cites this paper
• Gliclazide attenuates acetic acid-induced colitis via the modulation of PPARγ, NF-κB and MAPK signaling pathways.

  2020cites this paper
• Skin damage caused by scale loss modifies the intestine of chronically stressed gilthead sea bream (Sparus aurata, L.).

  2020cites this paper
• CD14 and ALPK1 Affect Expression of Tight Junction Components and Proinflammatory Mediators upon Bacterial Stimulation in a Colonic 3D Organoid Model

  2020cites this paper
• Macrophage polarization in intestinal inflammation and gut homeostasis

  2020cites this paper
• [Construction of rat interleukin-10 adenoviral vector and its expression in bone marrow mesenchymal stem cells].

  2019influential citation
• Immunobiotic Strains Modulate Toll-Like Receptor 3 Agonist Induced Innate Antiviral Immune Response in Human Intestinal Epithelial Cells by Modulating IFN Regulatory Factor 3 and NF-κB Signaling

  2019cites this paper
• Nanotechnology in the Treatment of Inflammatory Bowel Disease.

  2019cites this paper
• Total Glycosides of Peony Protects Against Inflammatory Bowel Disease by Regulating IL-23/IL-17 Axis and Th17/Treg Balance.

  2019cites this paper
• Optimization of the traditional processing method for precision detoxification of CaoWu through biomimetic linking kinetics and human toxicokinetics of aconitine as toxic target marker.

  2019cites this paper
• Lamin A/C deficiency in CD4+ T‐cells enhances regulatory T‐cells and prevents inflammatory bowel disease

  2019cites this paper
• Inhibition of tumor necrosis factor alpha and increased of interleukin 10 by Lactobacillus: a molecular mechanism protection against TNBS-induced ulcerative colitis in chicks

  2019cites this paper
• Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin‐induced thrombocytopenia

  2018cites this paper
• Functional capabilities of probiotic strains on attenuation of intestinal epithelial cell inflammatory response induced by TLR4 stimuli

  2018cites this paper
• Effet anti-inflammatoire et anti obésité des extraits polyphénoliques de feuilles de caroube "Ceratonia siliqua" et cladode de figuier de barbarie "Opuntia ficus-indica"

  2018cites this paper
• Impaired neutrophil extracellular traps and inflammatory responses in the peritoneal fluid of patients with liver cirrhosis

  2018cites this paper
• Whole Tart Cherry Improves Disease Activity Index in Rat Model of Dextran Sulfate Solution � Induced Ulcerative Colitis by Downregulating the Janus 1 And Janus 3 Kinases and TNF - Alpha

  2018cites this paper
• Nutraceuticals in rodent models as potential treatments for human Inflammatory Bowel Disease

  2018cites this paper
• Ameliorating effect of TI‐1‐162, a hydroxyindenone derivative, against TNBS‐induced rat colitis is mediated through suppression of RIP/ASK‐1/MAPK signaling

  2018cites this paper
• The Dynamics of Interleukin-10-Afforded Protection during Dextran Sulfate Sodium-Induced Colitis

  2018cites this paper
• Anthocyanins in chronic inflammatory bowel disease in rats

  2018cites this paper
• Immunological pathogenesis of inflammatory bowel disease

  2018cites this paper
• Interleukin-10: A Compelling Therapeutic Target in Patients With Irritable Bowel Syndrome.

  2017cites this paper
• A Proposal for a Study on Treatment Selection and Lifestyle Recommendations in Chronic Inflammatory Diseases: A Danish Multidisciplinary Collaboration on Prognostic Factors and Personalised Medicine

  2017influential citation
• Syddansk Universitet A Proposal for a Study on Treatment Selection and Lifestyle Recommendations in Chronic Inflammatory Diseases

  2017influential citation
• Interleukin-10-Loaded Nano- and Microparticles for the Local Treatment of the Intestinal Mucosa and the Deep Lung

  2017cites this paper
• Interleukin-4 and Interleukin-10 Gene Polymorphisms in Patients with Inflammatory Bowel Disease

  2017cites this paper
• IBD immunopathogenesis: A comprehensive review of inflammatory molecules.

  2017cites this paper
• Anti-inflammatory intestinal activity of Combretum duarteanum Cambess. in trinitrobenzene sulfonic acid colitis model

  2017cites this paper
• rSj16 Protects against DSS-Induced Colitis by Inhibiting the PPAR-α Signaling Pathway

  2017cites this paper
• Immunopathogenesis of IBD: current state of the art

  2016cites this paper
• IL-10/microRNA-155/SHIP-1 signaling pathway is crucial for commensal bacteria induced spontaneous colitis.

  2016cites this paper
• Intestinal-borne dermatoses significantly improved by oral application of Escherichia coli Nissle 1917.

  2016cites this paper
• The relationship between the immune system and oral manifestations of inflammatory bowel disease: a review

  2016cites this paper
• Immunomodulatory Activity of Water Extract of Ulmus macrocarpa in Macrophages

  2016cites this paper
• Inflammatory Bowel Disease: The Association of Inflammatory Cytokine Gene Polymorphisms

  2016cites this paper
• Mucosa-reparing and microbiota-balancing therapeutic effect of Bacillus subtilis alleviates dextrate sulfate sodium-induced ulcerative colitis in mice

  2016cites this paper
• Immunomodulatory Activity of Water Extract of Ulmus macrocarpa in Macrophages

  2016cites this paper
• Experimental colitis models: Insights into the pathogenesis of inflammatory bowel disease and translational issues.

  2015cites this paper
• Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy.

  2015cites this paper
• In vitro anti-inflammatory activity of selected oxalate-degrading probiotic bacteria: potential applications in the prevention and treatment of hyperoxaluria.

  2014cites this paper
• Longitudinal analysis of inflammation and microbiota dynamics in a model of mild chronic dextran sulfate sodium-induced colitis in mice.

  2014cites this paper
• IFN-γ–Mediated Induction of an Apical IL-10 Receptor on Polarized Intestinal Epithelia

  2014cites this paper
• Translational research and efficacy of biologics in Crohn's disease: a cautionary tale

  2014cites this paper
• Control of intestinal inflammation by interleukin-10.

  2014cites this paper
• Phototherapy with artificial light suppresses dextran sulfate sodium‐induced colitis in a mouse model

  2014cites this paper
• Optimising preparation of intestinal mucosal tissue and intestinal contents to study effects of "Akkermansia spp." supplementation during dextran sulfate sodium-induced colitis in mice

  2014cites this paper
• Inflammatory bowel disease: etiology, pathogenesis and current therapy.

  2014cites this paper
• Camel's milk ameliorates TNBS-induced colitis in rats via downregulation of inflammatory cytokines and oxidative stress.

  2014influential citation
• Telmisartan Attenuates Colon Inflammation, Oxidative Perturbations and Apoptosis in a Rat Model of Experimental Inflammatory Bowel Disease

  2014cites this paper
• The association between three promoter polymorphisms of IL-10 and inflammatory bowel diseases (IBD): A meta-analysis

  2014cites this paper
• Investigational cytokine-targeted therapies for ulcerative colitis

  2013cites this paper
• Review: new anti-cytokines for IBD: what is in the pipeline?

  2013cites this paper
• Why interleukin-10 supplementation does not work in Crohn's disease patients.

  2013cites this paper
• Interleukin-10-1082A/G polymorphism and inflammatory bowel disease susceptibility: a meta-analysis based on 17,585 subjects.

  2013cites this paper
• Nucleotide-Binding Oligomerization Domain 2 Signaling Promotes Hyperresponsive Macrophages and Colitis in IL-10–Deficient Mice

  2013cites this paper
• Murine Model of Chemically Induced Colitis Protective Effect of Tapeworm Infection in a Neutralizing Anti-IL-10 Antibody Blocks the

  2013cites this paper
• Ulmus davidiana var. japonica Nakai Upregulates Eosinophils and Suppresses Th1 and Th17 Cells in the Small Intestine

  2013cites this paper